...Phosphoinositide 3-kinaseRET – Ret proto-oncogene Paul Bonanos PLX8394 Novellus Ltd. Fore Biotherapeutics Inc....

...Cancer diagnostic company Cancer Genetics Inc. (NASDAQ:CGIX) will merge with NovellusDx Ltd. (Jerusalem, Israel). NovellusDx shareholders...
...will have a 49% equity stake in the company, which will retain Cancer Genetics’ name. NovellusDx’s...
...NovellusDx also will provide up to $2.3 million in a bridge loan to Cancer Genetics. NovellusDx...

...cytoplasm to the nucleus to stimulate cell proliferation. "Passenger" mutations don't result in nuclear translocation. NovellusDx's...
...mutations in a patient's tumor result in translocation to distinguish the passenger and driver mutations. NovellusDx...
...Institutions Mentioned American Society of Clinical Oncology (ASCO), Alexandria, Va. NovellusDx Ltd., Jerusalem, Israel Sidebars NovellusDx...